P&S Journal: Winter 1995, Vol.15, No.1
The Renaissance Reshaping Cancer at CPMC
Other Staff Changes
In the 1990s, CPMC has been aggressive in hiring cancer experts. In addition to Dr. Antman, new experts include Dr. David Kinne, professor of surgery with an expertise in breast cancer, recruited in 1993 (he was chief of the breast surgical service at Memorial Sloan-Kettering Cancer Center in New York); Dr. Charles Lightdale, professor of clinical medicine and gastroenterology recruited in 1993 (he was director of endoscopic research at Memorial Sloan-Kettering); Dr. Peter Schiff, chairman of radiation oncology, recruited in 1992; Dr. Paul Meier, chairman of biostatistics, recruited in 1992; Dr. Cy Stein, assistant professor of medicine and of pharmacology and Irving clinical research scholar, recruited in 1990; Dr. Alan Yagoda, professor of clinical medicine, recruited in 1991; and Dr. Daniel Petrylak, assistant professor of clinical medicine, recruited in 1991.
To bolster clinical trials efforts in cancer, Stuart Herna was named director of the CPMC tumor registry last fall. Re-established after a three-year hiatus, the tumor registry is a joint university-hospital effort.
Dr. Antman is hoping to recruit additional clinical investigators with expertise in leukemia and lymphoma, and breast, brain, lung, and gastrointestinal tract cancers. She also plans to expand the bone marrow transplantation/stem cell program.
Cancer is the second leading cause of death in the United States and, unless trends are reversed, will be the leading cause of death by the year 2010. Today, one person dies of cancer every 62 seconds.
"CPMC's full frontal attack on cancer expects to be instrumental in shifting the epidemiological curves to a more life-saving direction," says Dr. Pardes.